In this month’s Kieger AG’s Chart of the Month, we focus on the impressive success of Moderna, BioNTech SE/Pfizer and their partners in increasing the production capacity of their COVID-19 mRNA vaccines. Since the initial announcement of 1bn doses for 2021 in July 2020, Moderna and BioNTech/Pfizer have jointly increased capacity by 300% to 4bn for 2021 in just 10/11 months. For 2022, doses have been increased to 6bn from the 1.2bn announced in January.